PharVision Advisers’s Golub Capital BDC GBDC Stock Holding History

PharVision Advisers’s Portfolio GBDC Stock Details GBDC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,201	Closed	-$181K	–	803
2025 Q3	$181K	Buy	+13,201	New	+$194K	0.1%	537

Other funds holding GBDC

STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

AIM

Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's GBDC Position: Q4 2025 in Review

PharVision Advisers sold out of Golub Capital BDC (GBDC) in Q4 2025, closing a stake of 13,201 shares — an estimated $181K sold.

PharVision Advisers first reported a position in GBDC in Q3 2025 and held it in 1 quarter. The position peaked at $181K in Q3 2025. 354 funds tracked by Wall St. Rank hold GBDC as of Q4 2025.

PharVision Advisers reported no remaining Golub Capital BDC position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 13,201 Golub Capital BDC shares in Q4 2025, an estimated $181K.
PharVision Advisers first reported a position in Golub Capital BDC in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Golub Capital BDC position peaked at $181K in Q3 2025.
354 funds tracked by Wall St. Rank held Golub Capital BDC as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.